<DOC>
	<DOCNO>NCT01701895</DOCNO>
	<brief_summary>The purpose research study evaluate easy female HIV- positive subject take Complera comply dietary requirement use food diary short term ( 4 week ) long term ( 24 week 48 week ) determine association calorie intake virologic suppression . A secondary goal study evaluate subject ' attitude towards contraception .</brief_summary>
	<brief_title>Assessing Short Long Term Compliance With Caloric Intake HIV Positive Women Taking Complera</brief_title>
	<detailed_description />
	<criteria>1 . HIV1 infection document HIV serology detectable viral load point prior study entry documentation confirm HIV infection . If documentation available confirm HIV infection , rapid test may perform document HIV infection . 2 . HIV+ female â‰¥18 year old obtain care UNC Health Care Infectious Diseases Clinic , Wake County Human Services Clinic , Durham County Early Intervention Clinic . Patients receive care clinic may enter approval study team . 3 . HIV viral load ( VL ) &lt; 50 copies/ml measure FDAapproved test quantify HIV1 RNA six month prior study entry ( PSE ) . The timing viral load may longer 6 month depend schedule last clinic visit attend subject . The intent protocol assess viral load status previous clinic visit may occur interval longer six month due schedule constraint UNC Infectious Diseases clinic . Viral load draw &gt; 6 month ( &gt; 8 month ) prior study entry visit acceptable . A single `` blip '' &gt; 50 &lt; 200 copies/ml permissible provide recent VL &lt; 50 copies/ml . 4 . No documented resistance FTC , TDF rilpivirine . Note : genotyping perform study . Subjects historical genotype consider documented resistance . 5 . Able willing provide inform consent . 6 . In opinion investigator , able comply study medication procedure , include ability complete food diary . 7 . Willing receive monthly phone call . 8 . Agreement ID clinic provider study team clinical monitoring care patient reside ID clinic provider . The study responsibility limit provide 48 week Complera . 1 . Any condition , opinion investigator , would likely interfere ability take study medication appropriately comply study protocol . 2 . Current active illness require systemic treatment and/or hospitalization individual complete therapy , opinion investigator , clinically stable therapy least 7 day prior study entry . 3 . Acute viral hepatitis . 4 . Known allergy/hypersensitivity component study drug formulation . 5 . Current expect use medication prohibit medication list .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Complera</keyword>
	<keyword>short-term</keyword>
	<keyword>long-term</keyword>
	<keyword>compliance</keyword>
	<keyword>caloric</keyword>
	<keyword>intake</keyword>
	<keyword>HIV</keyword>
	<keyword>positive</keyword>
	<keyword>woman</keyword>
</DOC>